Literature DB >> 10206237

14-3-3 protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia.

K Toyooka1, T Muratake, T Tanaka, S Igarashi, H Watanabe, H Takeuchi, S Hayashi, M Maeda, M Takahashi, S Tsuji, T Kumanishi, Y Takahashi.   

Abstract

Recent genetic analyses have suggested a linkage between schizophrenia and the chromosomal region 22q12-q13. 14-3-3 protein, abundant in the brain, mediates interactions between diverse molecules of biological activities; its gene was recently mapped to chromosome 22q12.1-q13.1. We therefore investigated allele frequencies of a variable number of tandem repeat (VNTR) in the 5'-noncoding region of the 14-3-3 eta chain gene in controls and schizophrenics. The frequencies of the two-repeat allele were significantly higher (P < 0.05) in the schizophrenics, and particularly in those with onset before age 22 (early-onset schizophrenics, P < 0.02), than in the controls. The odds ratio was significantly increased in the early-onset schizophrenics homozygous for the two-repeat allele (OR = 3.3, 95% CI = 1.1-9.7). The 14-3-3 eta chain gene is a potential susceptibility gene for schizophrenia, and particularly for early-onset schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206237

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  27 in total

Review 1.  Recent advances in the genetics of schizophrenia.

Authors:  D M Waterwort; A S Bassett; L M Brzustowicz
Journal:  Cell Mol Life Sci       Date:  2002-02       Impact factor: 9.261

Review 2.  Consummating signal transduction: the role of 14-3-3 proteins in the completion of signal-induced transitions in protein activity.

Authors:  Paul C Sehnke; Justin M DeLille; Robert J Ferl
Journal:  Plant Cell       Date:  2002       Impact factor: 11.277

Review 3.  The 14-3-3 proteins: gene, gene expression, and function.

Authors:  Yasuo Takahashi
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

4.  14-3-3 proteins in neurological disorders.

Authors:  Molly Foote; Yi Zhou
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

5.  Transmission disequilibrium test provides evidence of association between promoter polymorphisms in 22q11 gene DGCR14 and schizophrenia.

Authors:  H Wang; S Duan; J Du; X Li; Y Xu; Z Zhang; Y Wang; G Huang; G Feng; L He
Journal:  J Neural Transm (Vienna)       Date:  2006-01-25       Impact factor: 3.575

Review 6.  Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models.

Authors:  Chi-Ying Lin; Akira Sawa; Hanna Jaaro-Peled
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

7.  A polymorphism in the YWHAH gene encoding 14-3-3 eta that is not associated with sporadic Creutzfeldt-Jakob disease (CJD).

Authors:  Jisuk Yun; Byung-Hoon Jeong; Hae-Jung Kim; Young-Jae Park; Yun-Jung Lee; Eun-Kyoung Choi; Richard I Carp; Yong-Sun Kim
Journal:  Mol Biol Rep       Date:  2011-07-08       Impact factor: 2.316

Review 8.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

9.  Increases in expression of 14-3-3 eta and 14-3-3 zeta transcripts during neuroprotection induced by delta9-tetrahydrocannabinol in AF5 cells.

Authors:  Jia Chen; Chun-Ting Lee; Stacie L Errico; Kevin G Becker; William J Freed
Journal:  J Neurosci Res       Date:  2007-06       Impact factor: 4.164

Review 10.  Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders.

Authors:  Aidong Yuan; Ralph A Nixon
Journal:  Brain Res Bull       Date:  2016-09-05       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.